Clinical Trial

ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single Dose

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a Phase 1, first-in-human study to evaluate the safety, tolerability, and pharmacokinetics of ORKA-002 in healthy participants.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-23; most recent amendment 2025-09-25.
Status change: Recruiting → Active, Not Recruiting 2025-09-25
Status change: Not Yet Recruiting → Recruiting 2025-05-14
Trial Details
NCT Number NCT06944379
Lead Sponsor Oruka Therapeutics, Inc.
Conditions Healthy Volunteers
Enrollment 24 participants
Start Date 2025-05-19
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-26